Unsafe Ingredients Included in Malaysian Food Drug Interphase (FDI) Products: Toyyiban perspective

Author:

Aziz Atiqah1,Bakar Norkartini Abu1,Zakaria Zalina1

Affiliation:

1. Universiti Malaya Pantai , Kuala Lumpur Malaysia .

Abstract

Abstract There are more than 24.1 % of the world’s population are Muslim. Considering the religious preference, Drug Control Authority (DCA) requires manufacturers to declare clearly if their products contain materials of animal origin, as well as unsafe drugs. In general, Health supplements, herbal products, and traditional medicine are classified as “food-drug interphase (FDI) products. FDI products are products with a combination of food ingredients and active ingredients for oral consumption. FDI products are widely believed to be able to prevent or even cure many diseases. However, over the past ten years, there are various FDI products in Malaysia contain dangerous drugs. Hence, this study summarizes the harmful effect of listed unsafe drugs possess in the FDI products, the category of the product, and the type of claim. According to the National Pharmaceutical Regulatory Agency (NPRA) recent report, there are 162 FDI products have been mixed up with illegal drugs which majority of them contain Dexamethasone. The most category of products that contain unsafe drugs is among traditional medicine products followed by health supplements, herbal supplement products, and dietary supplements. These products were commonly marketed to strengthen the veins & joint and pain relief, weight loss, sexual enhancement, energy booster, relieve sinus, and gout. Hence, an awareness of adulteration in pharmaceuticals is crucial to ensure the quality, safety, and effectiveness of the products towards human health.

Publisher

Walter de Gruyter GmbH

Subject

General Engineering

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3